Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| RELL | 144 | neutral | 2/10 | Director Kenneth Halverson filed a Form 144 notice of intent to sell 1,000 shares of Richardson Electronics common stock | Oct 29, 2026 |
| ACP | SC 13G/A | neutral | 3/10 | UBS Group AG filed an amended Schedule 13G disclosing a passive 28.83% stake in abrdn Income Credit Strategies Fund as o | Oct 29, 2026 |
| MGN | PRESS-RELEASE | bearish | 6/10 | Megan Holdings Limited closed a follow-on public offering of 15 million Class A ordinary shares at $0.50 per share, rais | Oct 29, 2026 |
| AIBT | SC 13G | neutral | 3/10 | Toby Allen Harris filed a Schedule 13G disclosing a 15.4% passive stake in AIBOTICS, INC. as of September 15, 2026. The | Oct 29, 2026 |
| CRBP | SC 13G/A | bearish | 4/10 | Aberdeen Group plc filed an amended Schedule 13G disclosing a reduction of its beneficial ownership in Corbus Pharmaceut | Oct 29, 2026 |
| VCIG | 6-K | neutral | 4/10 | VCI Global Ltd announced a 1-for-18 reverse stock split effective November 2, 2026, to regain compliance with Nasdaq's m | Oct 29, 2026 |
| TECX | SC 13G/A | bearish | 4/10 | Aberdeen Group plc filed an amended Schedule 13G disclosing a 2.48% passive stake (484,887 shares) in Tectonic Therapeut | Oct 29, 2026 |
| STM | 6-K | neutral | 3/10 | STMicroelectronics announced organizational changes and leadership appointments, including the confirmation of Remi El-O | Oct 29, 2026 |
| SUJA | SC 13G/A | neutral | 2/10 | Principal Global Investors filed an amended Schedule 13G disclosing a passive stake of 849 shares in Suja Life, Inc. as | Oct 29, 2026 |
| FMBM | 8-K | neutral | 4/10 | F&M Bank Corp. reported Q3 2026 net income of $2.64 million ($0.74 per diluted share), down 50.8% from Q2 2026's $5.37 m | Oct 29, 2026 |
| NICE | SC 13G/A | neutral | 3/10 | Principal Global Investors filed an amended Schedule 13G disclosing a 5.6% passive stake in NICE Ltd. as of September 30 | Oct 29, 2026 |
| NHP | SC 13G/A | neutral | 3/10 | Principal Global Investors and its affiliates filed an amended Schedule 13G for National Healthcare Properties, Inc., re | Oct 29, 2026 |
| STM | 6-K | bullish | 6/10 | STMicroelectronics reported Q3 2026 net revenues of $3.76B, above the consensus of $3.72B, and GAAP diluted EPS of $0.31 | Oct 29, 2026 |
| COLL | SC 13G/A | neutral | 3/10 | Principal Global Investors filed an amended Schedule 13G disclosing a 4.7% passive stake in Collegium Pharmaceutical as | Oct 29, 2026 |
| CSTL | SC 13G/A | neutral | 2/10 | Principal Global Investors filed an amended Schedule 13G disclosing a 4.9% passive stake in Castle Biosciences, represen | Oct 29, 2026 |
| BIPH | SC 13G/A | neutral | 2/10 | Principal Global Investors, LLC filed an amended Schedule 13G disclosing a passive 2.8% stake (13,054,426 limited partne | Oct 29, 2026 |
| NACB | 425 | neutral | 5/10 | ODNB Financial Corp and National Capital Bancorp (NACB) filed their Q3 2026 earnings alongside an update on their pendin | Oct 29, 2026 |
| ARDC | SC 13G/A | neutral | 3/10 | Principal Life Insurance Co. and Principal Global Investors filed an amended Schedule 13G disclosing a passive 160,000-s | Oct 29, 2026 |
| NACB | 8-K | neutral | 5/10 | ODNB Financial Corp reported strong Q3 2026 results with net interest income up 27.3% YoY to $13.0 million and net inter | Oct 29, 2026 |
| RDAC | 8-K | neutral | 3/10 | Rising Dragon Acquisition Corp. issued two unsecured promissory notes totaling $55,637.41 to extend its deadline to comp | Oct 29, 2026 |
| KMT | 8-K | neutral | 2/10 | Kennametal held its annual shareholder meeting on October 27, 2026, where all nine director nominees were elected, the a | Oct 29, 2026 |
| H | SC 13G/A | neutral | 3/10 | Principal Global Investors filed an amended Schedule 13G disclosing a 9.4% passive stake in Hyatt Hotels Corp as of Sept | Oct 29, 2026 |
| VISM | SC 13D/A | neutral | 5/10 | Mark B. Lucky, the CFO and sole director of Visium Technologies, filed Amendment No. 1 to his Schedule 13D to correct hi | Oct 29, 2026 |
| TRAD | SC 13G/A | neutral | 2/10 | UBS Group AG filed an amendment to its Schedule 13G for APEX Tech Acquisition Inc., reporting a 0.0% stake with zero sha | Oct 29, 2026 |
| DAL | 144 | neutral | 3/10 | Delta Air Lines CEO Edward Bastian filed a Form 144 notice of intent to sell 50,000 shares of common stock, with an appr | Oct 29, 2026 |
| ZTEKF | 6-K | neutral | 2/10 | Zentek Ltd. filed its management information circular for the annual and special meeting of shareholders scheduled for N | Oct 29, 2026 |
| XFOR | 8-K | neutral | 4/10 | X4 Pharmaceuticals held an Investor Day on October 29, 2026, providing an update on its lead drug candidate mavorixafor | Oct 29, 2026 |
| WFC | COURT-RULING | neutral | 1/10 | The Massachusetts Supreme Judicial Court affirmed the denial of a pro se petitioner's request for extraordinary relief u | Oct 29, 2026 |
| EFX | 144 | neutral | 2/10 | John W. Gamble Jr., an officer of Equifax, filed a Form 144 notice of intent to sell 4,000 shares of common stock, with | Oct 29, 2026 |
| SHEL | 6-K | neutral | 3/10 | Shell plc announced a Q3 2026 interim dividend of $0.3906 per ordinary share ($0.7812 per ADS), the 2027 interim dividen | Oct 29, 2026 |